UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025748 |
|---|---|
| Receipt number | R000029219 |
| Scientific Title | A phase II study of a short bevacizumab infusion in patients with metastatic colorectal cancer. |
| Date of disclosure of the study information | 2017/04/03 |
| Last modified on | 2020/01/22 16:01:28 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/01/19 17:38:53 | ||
| 2 | Update | 2017/02/15 15:44:27 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 3 | Update | 2017/02/15 15:53:06 | Interventions/Control_1 Interventions/Control_1 Target sample size |
|
| 4 | Update | 2017/02/15 15:53:38 | Date of disclosure of the study information |
|
| 5 | Update | 2017/03/27 19:45:14 | Date of protocol fixation Anticipated trial start date |
|
| 6 | Update | 2020/01/22 15:58:49 | Last follow-up date Date analysis concluded |
|
| 7 | Update | 2020/01/22 16:01:28 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
